Capital Fund Management S.A. Buys 40,057 Shares of McKesson Co. (NYSE:MCK)

Capital Fund Management S.A. grew its position in McKesson Co. (NYSE:MCK - Free Report) by 111.3% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 76,034 shares of the company's stock after purchasing an additional 40,057 shares during the period. Capital Fund Management S.A. owned approximately 0.06% of McKesson worth $43,333,000 at the end of the most recent quarter.

A number of other hedge funds have also modified their holdings of MCK. Frank Rimerman Advisors LLC raised its stake in shares of McKesson by 2.2% during the 4th quarter. Frank Rimerman Advisors LLC now owns 807 shares of the company's stock worth $460,000 after purchasing an additional 17 shares in the last quarter. Old North State Trust LLC raised its position in McKesson by 1.6% during the third quarter. Old North State Trust LLC now owns 1,138 shares of the company's stock worth $563,000 after acquiring an additional 18 shares in the last quarter. Trust Co. of Vermont lifted its stake in McKesson by 4.8% in the fourth quarter. Trust Co. of Vermont now owns 393 shares of the company's stock valued at $224,000 after acquiring an additional 18 shares during the last quarter. Hemington Wealth Management lifted its stake in McKesson by 18.6% in the fourth quarter. Hemington Wealth Management now owns 115 shares of the company's stock valued at $65,000 after acquiring an additional 18 shares during the last quarter. Finally, First Western Trust Bank grew its position in shares of McKesson by 2.0% in the 4th quarter. First Western Trust Bank now owns 931 shares of the company's stock valued at $531,000 after acquiring an additional 18 shares during the period. 85.07% of the stock is currently owned by institutional investors.

Remove Ads

Insider Buying and Selling at McKesson

In other McKesson news, EVP Leann B. Smith sold 188 shares of the stock in a transaction that occurred on Wednesday, February 12th. The stock was sold at an average price of $609.59, for a total value of $114,602.92. Following the transaction, the executive vice president now owns 1,051 shares in the company, valued at approximately $640,679.09. This represents a 15.17 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Brian S. Tyler sold 8,961 shares of the business's stock in a transaction that occurred on Friday, February 14th. The shares were sold at an average price of $600.66, for a total value of $5,382,514.26. Following the sale, the chief executive officer now owns 69,625 shares of the company's stock, valued at approximately $41,820,952.50. This represents a 11.40 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 18,110 shares of company stock valued at $10,855,706. 0.11% of the stock is currently owned by insiders.

Analyst Ratings Changes

MCK has been the subject of several recent analyst reports. Bank of America raised their target price on shares of McKesson from $665.00 to $755.00 and gave the company a "buy" rating in a research note on Friday. Cfra Research downgraded McKesson from a "moderate buy" rating to a "hold" rating in a research note on Friday, April 4th. Citigroup dropped their price target on McKesson from $713.00 to $677.00 and set a "buy" rating on the stock in a research note on Friday, January 10th. StockNews.com downgraded shares of McKesson from a "strong-buy" rating to a "buy" rating in a report on Friday, February 14th. Finally, Wells Fargo & Company lifted their target price on shares of McKesson from $641.00 to $691.00 and gave the stock an "equal weight" rating in a report on Friday, March 14th. Three research analysts have rated the stock with a hold rating, thirteen have issued a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, McKesson presently has an average rating of "Moderate Buy" and a consensus target price of $668.50.

McKesson Price Performance

Shares of MCK stock traded down $1.76 on Tuesday, hitting $692.22. 291,880 shares of the company's stock were exchanged, compared to its average volume of 879,805. The stock has a market cap of $86.75 billion, a P/E ratio of 31.70, a price-to-earnings-growth ratio of 1.29 and a beta of 0.49. McKesson Co. has a 12 month low of $464.42 and a 12 month high of $728.32. The company has a 50 day moving average of $644.47 and a 200 day moving average of $595.30.

McKesson (NYSE:MCK - Get Free Report) last issued its earnings results on Wednesday, February 5th. The company reported $8.03 earnings per share for the quarter, missing analysts' consensus estimates of $8.60 by ($0.57). McKesson had a net margin of 0.82% and a negative return on equity of 181.26%. Sell-side analysts predict that McKesson Co. will post 32.77 EPS for the current fiscal year.

McKesson Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, April 1st. Investors of record on Monday, March 3rd were issued a $0.71 dividend. The ex-dividend date was Monday, March 3rd. This represents a $2.84 annualized dividend and a yield of 0.41%. McKesson's payout ratio is 13.00%.

McKesson Company Profile

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.